Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (718)	10/25/2002 2:18:59 PM
From: tuck	Read Replies (2) of 1005

Hmmm. BVF bails out early stage investors of ARNA for cheap, right as the Merck deal was being publicized. Bought more than 2 million shares for $5 each. Not a bad return already, with ARNA having traded up to $6.5 on that news. sec.gov BVF now holds some 7+ million shares of Arena, which is almost 28% of the outstanding shares. Not sure what BVF's average cost basis is, but that transaction sure brought it down. Wow. Wish I could make deals like that. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next